Biopharma News

May 22, 2014
By BioPharm International Editors
Cytovance Biologics and Selexys Pharmaceuticals enter an agreement for development of clinical trial materials.
May 20, 2014
By BioPharm International Editors
FDA issues complete response letter for Novartis' RLX030 for acute heart failure.
May 16, 2014
By BioPharm International Editors
Advanced Scientifics and Chemic Laboratories enter a three-year joint cooperation agreement to collaborate on product development projects.
May 15, 2014
By BioPharm International Editors
AstraZeneca will collaborate with the Medical Research Council Laboratory of Molecular Biology to fund a range of pre-clinical research projects.
May 13, 2014
By BioPharm International Editors
KBI Biopharma acquires Merck's microbial process development and manufacturing operations in Colorado.
May 12, 2014
By BioPharm International Editors
Shire expands rare disease portfolio with acquisition of Lumena Pharmaceuticals.
May 09, 2014
By BioPharm International Editors
Boehringer Ingelheim and Connexios Life Sciences announce global research collaboration agreement for AMPK agonists.
May 09, 2014
By BioPharm International Editors
Cumberland Pharmaceuticals and Gloria Pharmaceuticals invest $1 million each in Cumberland Emerging Technologies.
Apr 30, 2014
By BioPharm International Editors
BMS acquisition of iPierian advances BMS' pursuit of therapeutics for genetically defined diseases.
Apr 30, 2014
By BioPharm International Editors
Allergy Therapeutics announced that its Worthing facility has received its Certificate of GMP Compliance following recent inspection by the MHRA.
native1_300x100
lorem ipsum